125 related articles for article (PubMed ID: 35156879)
21. Cefepime monotherapy for treatment of febrile neutropenia in children.
Ariffin H; Ai CL; Lee CL; Abdullah WA
J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation.
Whited L; Grove M; Rose D; Rhodes NJ; Scheetz MH; O'Donnell JN; Neeb J; Thoele K; Jones DR; Lowe C; Moore D; Kiel PJ
Pharmacotherapy; 2016 Sep; 36(9):1003-10. PubMed ID: 27496678
[TBL] [Abstract][Full Text] [Related]
23. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
[TBL] [Abstract][Full Text] [Related]
24. Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.
Jimeno A; Arcediano A; Bazares S; Amador ML; González-Cortijo L; Ciruelos E; Robles L; Castellano D; Paz-Ares L; Lumbreras C; Hornedo J; Cortés-Funes H
Clin Transl Oncol; 2006 Dec; 8(12):889-95. PubMed ID: 17169762
[TBL] [Abstract][Full Text] [Related]
25. Daptomycin vs. glycopeptides in the treatment of febrile neutropenia: results of the Izmir matched cohort study.
Sipahi OR; Kahraman H; Erdem HA; Yetkin F; Kaya S; Demirdal T; Tunccan OG; Karasahin O; Oruc E; Cag Y; Kurtaran B; Ulug M; Kutlu M; Avci M; Oztoprak N; Arda B; Pullukcu H; Tasbakan M; Yamazhan T; Kandemir O; Dizbay M; Sipahi H; Ulusoy S
Infection; 2019 Apr; 47(2):259-266. PubMed ID: 30498901
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of cefepime versus ticarcilline/clavulanate as empirical treatment of febrile neutropenia in lymphoma patients.
Naseem A; Hussain Y; Ahmad B; Aziz MT; Ahmad M; Hameed H
J Pak Med Assoc; 2011 Jan; 61(1):18-22. PubMed ID: 22368896
[TBL] [Abstract][Full Text] [Related]
27. Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
Lee NH; Kang JM; Lee JW; Huh HJ; Lee NY; Yoo KH; Sung KW; Koo HH; Kim YJ
Pediatr Infect Dis J; 2020 Oct; 39(10):931-936. PubMed ID: 32453199
[TBL] [Abstract][Full Text] [Related]
28. Cefepime versus imipenem-cilastatin as empirical monotherapy in 400 febrile patients with short duration neutropenia. CEMIC (Study Group of Infectious Diseases in Cancer).
Biron P; Fuhrmann C; Cure H; Viens P; Lefebvre D; Thyss A; Viot M; Soler-Michel P; Rollin C; Grès JJ
J Antimicrob Chemother; 1998 Oct; 42(4):511-8. PubMed ID: 9818751
[TBL] [Abstract][Full Text] [Related]
29. Retrospective Cohort Study of Clinical Efficacy and Safety of Cefozopran for Treating Febrile Neutropenia during Chemotherapy in Patients with Lung Cancer.
Higashionna T; Ushio S; Esumi S; Murakawa K; Kitamura Y; Sendo T
Acta Med Okayama; 2022 Apr; 76(2):167-172. PubMed ID: 35503444
[TBL] [Abstract][Full Text] [Related]
30. [Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor].
Marie-Cardine A; Schneider P; Blot N; Tron P; Vannier JP
Arch Pediatr; 2003 Apr; 10(4):307-12. PubMed ID: 12818750
[TBL] [Abstract][Full Text] [Related]
31. Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies.
Sime FB; Roberts MS; Tiong IS; Gardner JH; Lehman S; Peake SL; Hahn U; Warner MS; Roberts JA
Antimicrob Agents Chemother; 2015 Sep; 59(9):5463-9. PubMed ID: 26124158
[TBL] [Abstract][Full Text] [Related]
32. Dose Individualization of Cefepime for Febrile Neutropenia in Patients With Lymphoma or Multiple Myeloma: Implications for Therapeutic Drug Monitoring.
Oda K; Yamaguchi A; Matsumoto N; Nakata H; Higuchi Y; Nosaka K; Jono H; Saito H
Ther Drug Monit; 2024 Feb; 46(1):80-88. PubMed ID: 37735762
[TBL] [Abstract][Full Text] [Related]
33. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
[TBL] [Abstract][Full Text] [Related]
34. [Demographics, morbidity, and mortality febrile neutropenic adult patients treated with cefepime].
Puentes GA; Quiroga C; Alvarez CA; Támara JR; Ruiz A
Rev Chilena Infectol; 2012 Jun; 29(3):322-8. PubMed ID: 23096473
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Chong Y; Shimoda S; Yakushiji H; Ito Y; Miyamoto T; Kamimura T; Shimono N; Akashi K
PLoS One; 2013; 8(1):e54190. PubMed ID: 23372683
[TBL] [Abstract][Full Text] [Related]
36. Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia.
Gijsen M; Bekkers B; Maertens J; Lagrou K; Desmet S; Dreesen E; Peetermans WE; Debaveye Y; Spriet I
Int J Antimicrob Agents; 2022 Jan; 59(1):106472. PubMed ID: 34757136
[TBL] [Abstract][Full Text] [Related]
37. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
Cherif H; Björkholm M; Engervall P; Johansson P; Ljungman P; Hast R; Kalin M
Scand J Infect Dis; 2004; 36(8):593-600. PubMed ID: 15370671
[TBL] [Abstract][Full Text] [Related]
38. Cefepime versus ceftazidime + amikacin as empirical therapy for febrile neutropenia in children with cancer: a prospective randomized trial of the treatment efficacy and cost.
Corapçioglu F; Sarper N
Pediatr Hematol Oncol; 2005; 22(1):59-70. PubMed ID: 15770833
[TBL] [Abstract][Full Text] [Related]
39. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
40. Treatment of febrile neutropenia with cefepime monotherapy.
Jándula BM; Martino R; Gurgi M; Manteiga R; Sierra J
Chemotherapy; 2001; 47(3):226-31. PubMed ID: 11306793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]